___

• Langcake, P., and Pryce, R.J., “The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection and injury.” Physiology and Plant Pathology, 9: 77-86, (1976).
• Siemann, E.H., and Creasy, L.L., “Concentration of the phytoalexin resveratrol in wine.”, American Journal of Enology and Viticulture, 43: 49-52, (1992).
• Frankel, E.N., Kanner, J., German, J.B., Parks, E., and Kinsella, J.E., “Inhibition of oxidation of human-low density lipoprotein by phenolic substances in red wine.”, Lancet, 341: 454-457, (1993).
• Frankel, E.N., Waterhouse, A.L., and Kinsella, J.E., “Inhibition of human LDL oxidation by resveratrol.”, Lancet, 341: 1103-1104, (1993).
• Constant, J., “Alcohol, ischemic heart disease, and the French paradox.”, Coronary Artery Disease, 8: 645-649, (1997).
• Belguendouz, L., Fremont, L., and Linard, A., “Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins.”, Biochemical Pharmacology, 53: 1347-1355, (1997).
• Belguendouz, L., Fremont, L., and Gozzelino, M.T., “Interaction of trans resveratrol with plasma lipoproteins.”, Biochemical Pharmacology, 55: 811-816, (1998).
• Wilson, T., Knight, T.J., Beitz, D.C., Lewis, D.S., and Engen, R.L., “Resveratrol promotes atherosclerosis in hypercholesterolemic rabbits.”, Life Sciences, 59: 15-21, (1996).
• Turrens, J.E., Lariccia, J., and Nair, M.G., “Resveratrol has no effect on lipoprotein profile and does not prevent peroxidation of serum lipids in normal rats.”, Free Radical Research, 27: 557- 562, (1997).
• Chipman, J.K., Davies, J.E., Parsons, J.L., Nair, J., O’Neill, G., and Fawell, J.K., “DNA oxidation by potassium bromate; a direct mechanism or linked to lipid peroxidation.”, Toxicology, 126(2): 93– 102, (1998).
• Cadenas, S., and Barja, G., “Resveratrol, melatonin, vitamin E, and PBN protect against renal oxidative DNA damage induced by the kidney carcinogen KBrO3.”, Free Radical Biology and Medicine, 26: 1531–1537, (1999).
• Sai, K., Takagi, A., Umemura, T., Hasegawa, R., and Kurokawa, Y., “Relation of 8- hydroxydeoxyguanosine formation in rat kidney to lipid peroxidation, glutathione level and relative organ weight after a single administration of potassium bromate.”, Jpn. J. Cancer Res, 82: 165–169, (1991).
• Lee, Y.S., Choi, J.Y., Park, M.K., Choi, E.M., Kasai, H., and Chung, M.H., “Induction of OH8Gua glycosylase in rat kidneys by potassium 186
• GU J Sci., 24(2):181-186 (2011)/ Serhat KESER1♠, Okkes YILMAZ2, Mehmet TUZCU2
• bromate (KBrO3), a renal oxidative carcinogen.”,
• Mutation Research, 364: 227–233, (1996).
• DeAngelo, A.B., George, M.H., Kilburn, S.R., Moore, T.M., and Wolf, D.C., “Carcinogenicity of potassium bromate administered in the drinking water to male B6C3F1 mice and F344/N rats.”, Toxicol. Pathol, 26: 587–594, (1998).
• Wolf, D.C., Crosby, L.M., George, M.H., Kilburn, S.R., Moore, T.M., Miller, R.T., and DeAngelo, A.B., “Time- and dose-dependent development of potassium bromate-induced tumors in male Fischer 344 rats.”, Toxicol. Pathol, 26: 724–729, (1998).
• Dobrzyn, A., and Ntambi, J.M., “The role of stearoyl-CoA desaturase in body weight regulation.”, Trends in Cardiovascular Medicine, 14(2): 77–81, (2004).
• Ntambi, J.M., and Miyazaki, M., “Regulation of stearoyl-CoA desaturases and role in metabolism.”, Progress in Lipid Research, 43: 91–104, (2004).
• Hardy, S., El-Assad, W., Przybytkowski, E., Joly, E., Prentki, M., and Langelier, Y., “Saturated fatty acids induced apoptosis in MDA-MB-231 breast cancer cells: a role for cardiolipin.”, Journal of Biological Chemistry, 278: 31861–31870, (2003).
• Hara, A., and Radin, N.S., “Lipid extraction of tissues with a low-toxicity solvent.”, Analytical Biochemistry, 90: 420-426, (1978).
• Christie, W.W., “Gas chromatography and lipids”, The Oil Press, Glasgow, (1992).
• Wang, Z., Zou, J., Cao, K., Hsieh, T.C., Huang, Y.Z., and Wu, J.M., “Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels.”, Int. J. Mol. Med, 16: 533–540, (2005).
• Milde, J., Elstner, E.F., and Grabmann, J., “Synergistic effects of polyphenols and carotenoids on human low-density lipoprotein oxidation.”, Mol. Nutr. Food Res, 51: 956–961, (2007).
• Baur, J.A., and Sinclair, D.A., “Therapeutic potential of resveratrol: the in vivo evidence.”, Nat. Rev. Drug Discovery, 5: 493–506, (2006).
• Park, C.E., Kim, M.J., Lee, J.H., Min, B.I., Bae, H., Choe, W., Kim, S.S., and Ha, J., “Resveratrol stimulates glucose transport in C2C12 myotubes by activating AMP-activated protein kinase.”, Exp. Mol. Med, 39: 222–229, (2007).
• Ray, P.S., Maulik, G., Cordis, G.A., Bertelli, A.A.E., Bertelli, A., and Das, D.K., “The red wine antioxidant resveratrol protects isolated rat hearts fro ischemia reperfusion injury.”, Free Rad. Biol. Med, 27: 160–169, (1999).
• Stojanovic, S., Sprinz, H., and Brede, O., “Efficiency and mechanism of the antioxidant action of trans-resveratrol and its analogues in the radical liposome oxidation.”, Arch. Biochem. Biophys, 391: 79–89, (2001).
• Oak, M.H., Bedour, J.E., and Schini-Kerth, V.B., “Antiangiogenic properties of natural polyphenols from red wine and green tea.”, J. Nutr. Biochem, 16: 1–8, (2005).
• Baur, J.A., Pearson, K.J., Price, N.L., Jamieson, H.A., Lerin, C., Kalra, A., Prabhu, V.V., Allard, J.S., Lopez-Lluch, G., Lewis, K., Pistell, P.J., Poosala, S., Becker, K.G., Boss, O., Gwinn, D., Wang, M.Y., Ramaswamy, S., Fishbein, K.W., Spencer, R.G., Lakatta, E.G., Le Couteur, D., Shaw, R.J., Navas, P., Puigserver, P., Ingram, D.K., de Cabo, R., and Sinclair, D.A., “Resveratrol improves health and survival of mice on a high- calorie diet.” , Nature, 444: 337–342, (2006).
• Ajmo, J.M., Liang, X.M., Rogers, C.Q., Pennock, B., and You, M., “Resveratrol alleviates alcoholic fatty liver in mice.”, American Journal of Physiology-Gastrointestinal and Liver Physiology, 295(4): 833-842, (2008).
• Gnoni, G.V., and Paglialonga, G., “Resveratrol inhibits fatty acid and triacylglycerol synthesis in rat hepatocytes.”, European Journal of Clinical Investigation, 39(3), 211-218, (2009).
• Nakamura, M.T., and Nara, T.Y., “Structure, function, and dietary regulation of Delta 6, Delta 5, and Delta 9 desaturases.”, Annual Review of Nutrition, 24: 345-376, (2004).
• Cheul Kim, Y., and Nitambi, M., “Regulation of Stearoyl-CoA desaturase genes; role in cellular metabolism and preadipocyte differentiation.”, Biochemical and Biophysical Research Communications, 266: 1-4, (1999).
• Ntambi, J.M., “Regulations of Stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol.”, Journal of Lipid Research, 409: 1549-1558, (1999).
• Douillet, C., Chancerelle, Y., Cruz, C., Maroncles, C., Kergonou, J.F., Renaud, S., Ciavatti, M., “High dosage vitamin E effect on oxidative status and serum-lipids distribution in streptozotocin-induced diabetic rats.”, Biochemical Medicine and Metabolic Biology, 50: 265-276, (1993).
• Yiin, S.J., and Lin, T.H., “Lead-catalysed peroxidation of essential unsaturated fatty acid.” , Biological Trace Element Research, 50(2): 167- 172, (1995).
• Cohen, P, Zhao, C, Cai, X., Montez, J.M., Rohani, S.C., Feinstein, P., Mombaerts, P., and Friedman, J.M., “Selective deletion of leptin receptor in neurons leads to obesity.”, Journal of Clinical Investigation, 108: 1113–1121, (2001).